Despite bipartisan support, dedicated advocacy, and multiple legislative pushes, Oklahoma remains without an operational Rare Disease Advisory Council (RADC).
Designed to advise state agencies, educate lawmakers, and address the unique medical and financial challenges of Oklahomans living with rare conditions, RADCs have gained traction across the nation. In Oklahoma, however, efforts to establish a council have stalled in legislative committees or failed at the executive level.
2024: Stalled in Committee (Senate Bill 1772)
The initial push gained formal momentum during the 59th Legislature’s second regular session in early 2024.
Proposed Structure: Senate Bill 1772 aimed to establish a council within the Oklahoma State Department of Health (OSDH) with at least 17 members. It required annual reporting to the governor and legislative leaders, setting target deadlines for initial appointments by late 2024 and a first meeting in early 2025.
Key Sponsors: Primary author Sen. Carri Hicks, principal House author Rep. Jeff Boatman, and co-author Sen. Roland Pederson.
Legislative Path: Introduced on February 5, 2024, and referred to the Senate Health and Human Services Committee on February 6.
Why It Failed: SB 1772 never advanced out of committee to receive a recorded vote before the session ended. While public records confirm where it stopped, specific causes—such as committee workload, competing policy priorities, or budget considerations—were not formally documented.
2025: Passed Both Houses, Stopped by Executive Veto (Senate Bill 207)
Lawmakers renewed their efforts during the 60th Legislature’s first regular session in 2025 with Senate Bill 207.
Expanded Scope: Introduced by Sen. Tom Woods alongside principal House author Rep. Josh West and a broad group of coauthors, SB 207 proposed a 13-member council meeting quarterly. It also expanded to address Oklahoma's newborn screening program and proposed establishing a Newborn Screening Revolving Fund.
Legislative Path: SB 207 steadily progressed through the legislative process:
Feb 10–20, 2025: Approved by Senate Health and Human Services and Senate Appropriations committees.
March 27, 2025: Passed the full Senate (30–17).
April 9–23, 2025: Passed House Children, Youth, and Family Services and was considered by House Health and Human Services Oversight.
May 7, 2025: Passed the full House (78–11).
May 28, 2025: Passed final votes in both chambers and was sent to the governor.
Why It Failed: On June 15, 2025, Governor Kevin Stitt allowed the bill to die via a pocket veto by taking no action within the constitutional decision window following legislative adjournment. While media reports noted SB 207 was awaiting action among several health measures, no official statement was issued detailing specific executive policy objections.
Comparative Overview
2024 SB 1772: Primary author Sen. Carri Hicks proposed a 17+ member general advisory body; stalled in the Senate Health and Human Services Committee.
2025 SB 207: Primary author Sen. Tom Woods proposed a 13+ member body with newborn screening funding provisions; passed the Senate (30–17) and House (78–11); pocket-vetoed by the governor.
The Path Forward
The failure of these proposals highlights two major hurdles in Oklahoma's legislative process:
Committee Bottlenecks: Initial bills like SB 1772 can stall early in the process without reaching a floor vote.
Executive Alignment: Even measures like SB 207 that secure strong legislative majorities remain vulnerable to pocket vetoes if key executive priorities or concerns are left unaddressed before session adjournment.
Until future legislation successfully navigates both committee review and executive approval, Oklahoma families affected by rare conditions will remain without a centralized, state-sanctioned advisory council.